Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript
Okay, great. Welcome, everyone. This is a multi-company panel entitled Sickle Cell, Beta-Thal, ITP & PKD - Measuring Industry Progress in Benign Hematology. It's my pleasure to introduce the guests on the panel.
From Agios Pharmaceuticals, Jackie Fouse, who is the CEO of the company. Hi, Jackie. From Rigel Pharmaceuticals, Raul Rodriguez, the President and CEO; and Jonathan Schwartz, who is the CMO at Rocket Pharmaceuticals. And we have a fourth participant and hopefully will show up soon, Rahul Ballal, the CEO of IMARA. So welcome all of you. Thank you very, very much for your participation.
Questions & Answers
Maybe to get things started, for those less familiar with your companies and your pipelines, if each of you could spend 2 or 3 minutes just doing a high level, a summary of what you're focused on and what your pipeline looks like. Jackie, you want to kick it off?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
